Updating results
Showing: 1-25 of 17967
- Jeanine Santucci USA Today
Despite years of momentum to loosen restrictions on weed, there is still a big disconnect between states and the federal government.
News
- Benzinga - News
- Updated
Deloitte warned that GLP-1 weight loss and diabetes drugs are boosting pharma R&D returns while creating concentration and bubble risk acr…
- Ken Alltucker USA Today
- Updated
Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on prescription drugs this year, a new report says.
- John S Kiernan, WalletHub Managing Editor
Drug abuse has a long and storied history in the United States, and we’ve been “at war” with it for decades. Yet despite the country’s best efforts to fight it, the problem is still prevalent. There were more than
68,400drug overdose deaths in the 12-month period ending in October 2025, according to the CDC.
- Bhargav Acharya and Andrew Goudsward Reuters
- Updated
The decision to reclassify marijuana would represent one of the most significant federal changes to marijuana policy in decades, removing barriers to researching the drug's potential use cases.
- Howard Fischer
- Updated
An effort to take Arizona's marijuana law back to voters needs 255,949 valid signatures on petitions by July 2.
- Updated
More than with perhaps any other major issue of recent years, the federal government and the states have inhabited two starkly different realities regarding marijuana.